These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11531253)

  • 1. Analysis of the TGF beta functional pathway in epithelial ovarian carcinoma.
    Francis-Thickpenny KM; Richardson DM; van Ee CC; Love DR; Winship IM; Baguley BC; Chenevix-Trench G; Shelling AN
    Br J Cancer; 2001 Sep; 85(5):687-91. PubMed ID: 11531253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of mutations in the analysis of coding sequences of the entire transforming growth factor-beta type II receptor gene in sporadic human breast cancers.
    Takenoshita S; Mogi A; Tani M; Osawa H; Sunaga H; Kakegawa H; Yanagita Y; Koida T; Kimura M; Fujita KI; Kato H; Kato R; Nagamachi Y
    Oncol Rep; 1998; 5(2):367-71. PubMed ID: 9468559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
    Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
    Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
    Cardillo MR; Yap E; Castagna G
    J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
    Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
    Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches.
    Zhang Q; Capocasale RJ; Fox FE; Bedian V; Vonderheid EC; Rook A; Moore JS; Nowell PC; Haines DS; Wasik MA
    Arch Immunol Ther Exp (Warsz); 2002; 50(6):421-9. PubMed ID: 12546068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability and gene mutations in transforming growth factor-beta type II receptor are absent in small bowel carcinoid tumors.
    Kidd M; Eick G; Shapiro MD; Camp RL; Mane SM; Modlin IM
    Cancer; 2005 Jan; 103(2):229-36. PubMed ID: 15599934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of TGF-beta type II receptor, Smad2, Smad3, Smad4, Smad6 and Smad7 genes in colorectal cancer.
    Fukushima T; Mashiko M; Takita K; Otake T; Endo Y; Sekikawa K; Takenoshita S
    J Exp Clin Cancer Res; 2003 Jun; 22(2):315-20. PubMed ID: 12866583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of transforming growth factor beta receptor II, insulin growth factor receptor II genes in microsatellite unstable prostate carcinomas.
    Bhattacharyya N; Tao J; Klein EA; Banerjee S
    Oncol Rep; 2004 Jan; 11(1):231-6. PubMed ID: 14654931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
    Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
    Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
    Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHFR gene is neither mutated nor hypermethylated in ovarian cancer.
    Ludwig AH; Bujko M; Bidzinski M; Kupryjańczyk J
    Cancer Detect Prev; 2007; 31(3):257-61. PubMed ID: 17673375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of coordinated androgen regulation in nonmalignant ovarian epithelial cells with BRCA1/2 mutations and ovarian cancer cells.
    Evangelou A; Letarte M; Jurisica I; Sultan M; Murphy KJ; Rosen B; Brown TJ
    Cancer Res; 2003 May; 63(10):2416-24. PubMed ID: 12750261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
    Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite unstable colorectal cancer cell lines with truncating TGFbetaRII mutations remain sensitive to endogenous TGFbeta.
    Baker K; Raut P; Jass JR
    J Pathol; 2007 Nov; 213(3):257-65. PubMed ID: 17893910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of microsatellite instability target genes in sporadic basal cell carcinomas.
    Saetta AA; Stamatelli A; Karlou M; Michalopoulos NV; Patsouris E; Aroni K
    Pathol Res Pract; 2007; 203(12):849-55. PubMed ID: 17950544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer.
    Baxter SW; Choong DY; Eccles DM; Campbell IG
    Cancer Epidemiol Biomarkers Prev; 2002 Feb; 11(2):211-4. PubMed ID: 11867510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.